Canada's national advisory panel on immunization said earlier this month that authorized Covid-19 vaccines could be mixed, and noted some people might prefer to get a messenger RNA vaccine for their second shot. The panel has previously said mRNA vaccines, such as the ones produced by Pfizer Inc. in partnership with BioNTech SE, as well as Moderna Inc., are preferable to viral vector vaccines, such as those developed by AstraZeneca and Johnson & Johnson.
Turkey Commits to Securing Afghan Airport After Americans Leave, U.S. Says
WASHINGTON-The U.S. and Turkey have agreed to a plan for the Turks to continue providing security at the airport in Kabul, U.S. officials said, ensuring the U.S. and other nations can maintain a diplomatic presence in Afghanistan following the withdrawal of troops, expected by next month.
Jake Sullivan, President Biden's national security adviser, told reporters Thursday that both sides had made a "clear commitment" on the security of Hamid Karzai International Airport in Kabul.
Israel Strikes Militant Targets in Gaza After More Arson Attacks
JERUSALEM-The Israeli military hit the Gaza Strip with a series of airstrikes Thursday night, rattling a shaky month-old cease-fire between the two sides that mediators are trying to keep from falling apart.
Soon after, for the first time in nearly a month, air raid sirens sounded the alarm in southern Israel when Gaza militants used heavy machine guns to fire across the border, the Israeli military said.
Write to firstname.lastname@example.org
Expected Major Events for Friday
06:00/GER: May PPI
06:00/UK: May UK monthly retail sales figures
06:00/ROM: 1Q Employment and unemployment
08:00/POL: May Average gross wages
08:00/EU: Apr Euro area balance of payments
08:30/UK: May Bank of England/Kantar Inflation Attitudes Survey
08:30/UK: 1Q Bank of England statistics on UK banks' external claims
09:00/ITA: Apr Balance of Payments
10:00/POR: May PPI
15:59/GRE: Apr Balance of Payments
17:59/UK: CBI Economic Forecast
All times in GMT. Powered by Kantar Media and Dow Jones.
Write to us at email@example.com
We offer an enhanced version of this briefing that is optimized for viewing on mobile devices and sent directly to your email inbox. If you would like to sign up, please go to https://newsplus.wsj.com/subscriptions.
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires